Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) yesterday and set a price target of $26.00. Larry Biegelsen has given his Buy ...

TPG and Blackstone have partnered to bid for eye care company Bausch + Lomb Corporation, according to sources cited by the Financial Times. If successful, the transaction could become one of the ...

Bausch + Lomb has bought US and Canadian rights to a potential biosimilar competitor to Novartis’ Lucentis from Germany’s Stada, as the blockbuster approaches the end of its patent ...

Diaceutics, a technology provider to the pharma and biotech industry, appointed Sandra Blake as chief people officer. Cathleen McCabe, MD has joined Bausch + Lomb as strategic medical advisor.

Bausch Health turned down recent debt-restructuring proposals from bondholders as it explores a sale of its Bausch + Lomb vision care subsidiary that could bring in billions of dollars to pay ...

(Bloomberg) -- Banks and private credit firms are competing to provide at least $5 billion of debt financing to help fund a potential buyout of Bausch + Lomb, according to people with knowledge of ...

“I’m optimistic,” Bausch + Lomb CEO Brent Saunders told STAT. Zach Weinberg, CEO of Curie.Bio, said that while Trump’s policies on health care have been known to shift, “R.F.K. is scary ...

Brands like FreshLook, Bausch & Lomb ... Unlike regular contact lenses, toric lenses have different powers in different meridians to address this distortion, providing clearer and more comfortable ...

https://www.tipranks.com/news/the-fly/curis-price-target-lowered-to-20-from-26-at-h-c-wainwright ...